Found 23 hits Enz. Inhib. hit(s) with all data for assayid = 1 entry = 3437 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34017
(CHEMBL104850 | phenylpropanoic acid derivative, 7)Show SMILES Cc1oc(nc1CCOc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C25H24N2O4/c1-18-22(26-24(31-18)20-7-3-2-4-8-20)13-16-30-21-11-9-19(10-12-21)17-23(25(28)29)27-14-5-6-15-27/h2-12,14-15,23H,13,16-17H2,1H3,(H,28,29)/t23-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 29 | n/a | 26 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM33284
(BMC164883 Compound 53 | phenylpropanoic acid deriv...)Show SMILES Cc1oc(nc1CCCc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C26H26N2O3/c1-19-23(27-25(31-19)22-9-3-2-4-10-22)11-7-8-20-12-14-21(15-13-20)18-24(26(29)30)28-16-5-6-17-28/h2-6,9-10,12-17,24H,7-8,11,18H2,1H3,(H,29,30)/t24-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| MMDB
PDB
Article
PubMed
| n/a | n/a | 185 | n/a | 140 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34025
(phenylpropanoic acid derivative, 40)Show SMILES Cc1oc(nc1C\C=C\c1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C26H24N2O3/c1-19-23(27-25(31-19)22-9-3-2-4-10-22)11-7-8-20-12-14-21(15-13-20)18-24(26(29)30)28-16-5-6-17-28/h2-10,12-17,24H,11,18H2,1H3,(H,29,30)/b8-7+/t24-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 255 | n/a | 102 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34018
(phenylpropanoic acid derivative, 28)Show SMILES Cc1oc(nc1CC#Cc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C26H22N2O3/c1-19-23(27-25(31-19)22-9-3-2-4-10-22)11-7-8-20-12-14-21(15-13-20)18-24(26(29)30)28-16-5-6-17-28/h2-6,9-10,12-17,24H,11,18H2,1H3,(H,29,30)/t24-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 293 | n/a | 173 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34030
(phenylpropanoic acid derivative, 56 | racemic)Show SMILES Cc1oc(nc1CCCc1ccc(CC(C(O)=O)c2ccc(cc2)-c2ccccc2)cc1)-c1ccccc1 Show InChI InChI=1S/C34H31NO3/c1-24-32(35-33(38-24)30-12-6-3-7-13-30)14-8-9-25-15-17-26(18-16-25)23-31(34(36)37)29-21-19-28(20-22-29)27-10-4-2-5-11-27/h2-7,10-13,15-22,31H,8-9,14,23H2,1H3,(H,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 587 | n/a | 1.80E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34034
(phenylpropanoic acid derivative, 66)Show SMILES Cc1oc(nc1CCNc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C25H25N3O3/c1-18-22(27-24(31-18)20-7-3-2-4-8-20)13-14-26-21-11-9-19(10-12-21)17-23(25(29)30)28-15-5-6-16-28/h2-12,15-16,23,26H,13-14,17H2,1H3,(H,29,30)/t23-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.60E+3 | n/a | 480 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34027
(phenylpropanoic acid derivative, 44)Show SMILES CN(C\C=C\c1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)c1ccccc1 |r| Show InChI InChI=1S/C23H24N2O2/c1-24(21-9-3-2-4-10-21)15-7-8-19-11-13-20(14-12-19)18-22(23(26)27)25-16-5-6-17-25/h2-14,16-17,22H,15,18H2,1H3,(H,26,27)/b8-7+/t22-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | 3.70E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34020
(phenylpropanoic acid derivative, 30 | racemic)Show SMILES Cc1oc(nc1CC#Cc1ccc(CC(C(O)=O)c2ccc(cc2)-c2ccccc2)cc1)-c1ccccc1 Show InChI InChI=1S/C34H27NO3/c1-24-32(35-33(38-24)30-12-6-3-7-13-30)14-8-9-25-15-17-26(18-16-25)23-31(34(36)37)29-21-19-28(20-22-29)27-10-4-2-5-11-27/h2-7,10-13,15-22,31H,14,23H2,1H3,(H,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.20E+3 | n/a | 2.50E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34026
(phenylpropanoic acid derivative, 41)Show SMILES Cc1oc(nc1C\C=C\c1ccc(C[C@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C26H24N2O3/c1-19-23(27-25(31-19)22-9-3-2-4-10-22)11-7-8-20-12-14-21(15-13-20)18-24(26(29)30)28-16-5-6-17-28/h2-10,12-17,24H,11,18H2,1H3,(H,29,30)/b8-7+/t24-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.60E+3 | n/a | 2.60E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34021
(phenylpropanoic acid derivative, 31 | racemic)Show SMILES Cc1oc(nc1CC#Cc1ccc(CC(C(O)=O)c2cccc(c2)-c2ccccc2)cc1)-c1ccccc1 Show InChI InChI=1S/C34H27NO3/c1-24-32(35-33(38-24)28-13-6-3-7-14-28)17-8-10-25-18-20-26(21-19-25)22-31(34(36)37)30-16-9-15-29(23-30)27-11-4-2-5-12-27/h2-7,9,11-16,18-21,23,31H,17,22H2,1H3,(H,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.80E+3 | n/a | 1.30E+4 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34031
(phenylpropanoic acid derivative, 57 | racemic)Show SMILES Cc1oc(nc1CCCc1ccc(CC(C(O)=O)c2cccc(c2)-c2ccccc2)cc1)-c1ccccc1 Show InChI InChI=1S/C34H31NO3/c1-24-32(35-33(38-24)28-13-6-3-7-14-28)17-8-10-25-18-20-26(21-19-25)22-31(34(36)37)30-16-9-15-29(23-30)27-11-4-2-5-12-27/h2-7,9,11-16,18-21,23,31H,8,10,17,22H2,1H3,(H,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.80E+3 | n/a | 4.00E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34028
(phenylpropanoic acid derivative, 54)Show SMILES Cc1oc(nc1CCCc1ccc(C[C@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C26H26N2O3/c1-19-23(27-25(31-19)22-9-3-2-4-10-22)11-7-8-20-12-14-21(15-13-20)18-24(26(29)30)28-16-5-6-17-28/h2-6,9-10,12-17,24H,7-8,11,18H2,1H3,(H,29,30)/t24-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.10E+3 | n/a | 2.30E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM33296
(BMC164883 Compound 58 | phenylpropanoic acid deriv...)Show SMILES Cc1oc(nc1CCCc1ccc(CC(C(O)=O)c2ccccc2)cc1)-c1ccccc1 Show InChI InChI=1S/C28H27NO3/c1-20-26(29-27(32-20)24-12-6-3-7-13-24)14-8-9-21-15-17-22(18-16-21)19-25(28(30)31)23-10-4-2-5-11-23/h2-7,10-13,15-18,25H,8-9,14,19H2,1H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 4.00E+3 | n/a | 3.90E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34033
(phenylpropanoic acid derivative, 60)Show SMILES CN(CCCc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)c1ccccc1 |r| Show InChI InChI=1S/C23H26N2O2/c1-24(21-9-3-2-4-10-21)15-7-8-19-11-13-20(14-12-19)18-22(23(26)27)25-16-5-6-17-25/h2-6,9-14,16-17,22H,7-8,15,18H2,1H3,(H,26,27)/t22-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 1.10E+4 | n/a | 3.60E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34024
(phenylpropanoic acid derivative, 36)Show SMILES CN(C\C=C\c1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)c1ccccn1 |r| Show InChI InChI=1S/C22H23N3O2/c1-24(21-8-2-3-13-23-21)14-6-7-18-9-11-19(12-10-18)17-20(22(26)27)25-15-4-5-16-25/h2-13,15-16,20H,14,17H2,1H3,(H,26,27)/b7-6+/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.20E+4 | n/a | 492 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34023
(phenylpropanoic acid derivative, 33)Show SMILES CN(CC#Cc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)c1ccccc1 |r| Show InChI InChI=1S/C23H22N2O2/c1-24(21-9-3-2-4-10-21)15-7-8-19-11-13-20(14-12-19)18-22(23(26)27)25-16-5-6-17-25/h2-6,9-14,16-17,22H,15,18H2,1H3,(H,26,27)/t22-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.20E+4 | n/a | 2.00E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34029
(phenylpropanoic acid derivative, 55 | racemic)Show SMILES Cc1oc(nc1CCCc1ccc(CC(C(O)=O)c2cccnc2)cc1)-c1ccccc1 Show InChI InChI=1S/C27H26N2O3/c1-19-25(29-26(32-19)22-8-3-2-4-9-22)11-5-7-20-12-14-21(15-13-20)17-24(27(30)31)23-10-6-16-28-18-23/h2-4,6,8-10,12-16,18,24H,5,7,11,17H2,1H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.20E+4 | n/a | 3.90E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34019
(phenylpropanoic acid derivative, 29 | racemic)Show SMILES Cc1oc(nc1CC#Cc1ccc(CC(C(O)=O)c2cccnc2)cc1)-c1ccccc1 Show InChI InChI=1S/C27H22N2O3/c1-19-25(29-26(32-19)22-8-3-2-4-9-22)11-5-7-20-12-14-21(15-13-20)17-24(27(30)31)23-10-6-16-28-18-23/h2-4,6,8-10,12-16,18,24H,11,17H2,1H3,(H,30,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.60E+4 | n/a | 4.50E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34032
(phenylpropanoic acid derivative, 59)Show SMILES CN(CCCc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)c1ccccn1 |r| Show InChI InChI=1S/C22H25N3O2/c1-24(21-8-2-3-13-23-21)14-6-7-18-9-11-19(12-10-18)17-20(22(26)27)25-15-4-5-16-25/h2-5,8-13,15-16,20H,6-7,14,17H2,1H3,(H,26,27)/t20-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 2.80E+4 | n/a | 1.20E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34035
(phenylpropanoic acid derivative, 74)Show SMILES Cc1oc(nc1CNCc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1)-c1ccccc1 |r| Show InChI InChI=1S/C25H25N3O3/c1-18-22(27-24(31-18)21-7-3-2-4-8-21)17-26-16-20-11-9-19(10-12-20)15-23(25(29)30)28-13-5-6-14-28/h2-14,23,26H,15-17H2,1H3,(H,29,30)/t23-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | 9.00E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34022
(phenylpropanoic acid derivative, 32 | racemic)Show SMILES CN(CC#Cc1ccc(CC(C(O)=O)n2cccc2)cc1)c1ccccn1 Show InChI InChI=1S/C22H21N3O2/c1-24(21-8-2-3-13-23-21)14-6-7-18-9-11-19(12-10-18)17-20(22(26)27)25-15-4-5-16-25/h2-5,8-13,15-16,20H,14,17H2,1H3,(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 5.30E+4 | n/a | 9.00E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34036
(phenylpropanoic acid derivative, 75)Show SMILES CN(Cc1nc(oc1C)-c1ccccc1)Cc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1 |r| Show InChI InChI=1S/C26H27N3O3/c1-19-23(27-25(32-19)22-8-4-3-5-9-22)18-28(2)17-21-12-10-20(11-13-21)16-24(26(30)31)29-14-6-7-15-29/h3-15,24H,16-18H2,1-2H3,(H,30,31)/t24-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | 7.00E+3 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Peroxisome proliferator-activated receptor gamma
(Homo sapiens (Human)) | BDBM34037
(phenylpropanoic acid derivative, 76)Show SMILES CC(=O)N(Cc1nc(oc1C)-c1ccccc1)Cc1ccc(C[C@@H](C(O)=O)n2cccc2)cc1 |r| Show InChI InChI=1S/C27H27N3O4/c1-19-24(28-26(34-19)23-8-4-3-5-9-23)18-30(20(2)31)17-22-12-10-21(11-13-22)16-25(27(32)33)29-14-6-7-15-29/h3-15,25H,16-18H2,1-2H3,(H,32,33)/t25-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >1.00E+5 | n/a | >3.00E+4 | n/a | n/a | 7.4 | 23 |
Pfizer
| Assay Description
Human 6His-PPAR gamma ligand-binding domain was added to the mixture containing radioligand and test compound, followed by yttrium silicate polylysin... |
Bioorg Med Chem 16: 4883-907 (2008)
Article DOI: 10.1016/j.bmc.2008.03.043
BindingDB Entry DOI: 10.7270/Q2SN0797 |
More data for this
Ligand-Target Pair | |
Search and Browse
